Ruby Nanomed develops a microfluidic-based liquid biopsy device for cancer progression.
Ruby Nanomed's investors include European Innovation Council, Portugal Ventures.
Ruby Nanomed is headquartered in Braga, Portugal.
Ruby Nanomed develops a microfluidic-based liquid biopsy device for cancer progression.
Ruby Nanomed is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ruby Nanomed — Funding & Investors." VCBacked, August 24, 2023, https://www.vcbacked.co/company/ruby-nanomed. Accessed July 20, 2026.
VCBacked. (2023). Ruby Nanomed — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/ruby-nanomed
{{cite web |title=Ruby Nanomed — Funding & Investors |url=https://www.vcbacked.co/company/ruby-nanomed |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated